Rocuronium Bromide Injection 50mg/5 mL
Recall D-0019-2022, part of FDA recall event 88841. See Piramal Critical Care, Inc.'s company page.
Piramal Critical Care, Inc. started this Class II drug recall on Sep 10, 2021 (voluntary: firm initiated); FDA lists it as terminated, terminated Sep 7, 2022.
- Classification: Class II
- Started: Sep 10, 2021
- Status: Terminated
Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"
- Product
- Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for: Piramal Critical Care, Bethlehem, PA 18017, USA, Manufactured by: Sanovel Ilac, San. Ve Tic. A.S. Istanbul, Turkey, NDC 66794-0228-41
- Quantity
- 100 glass vials
- Lots and codes
- Lot #: 20415001, 20415002, Expiration Date 05/2022
- Distribution
- Nationwide within the United States
- Recalling firm
- Piramal Critical Care, Inc., Bethlehem, PA, United States
- How the firm notified
- Letter
- FDA classified
- Oct 20, 2021
Newest first, one product per recall event; search them all
- Gablofen (baclofen injection), 50 mcg/mL, Single Use Syringe, Rx only, packaged in a box containing one 1 mL syringe,…D-1742-2019 · Class II · Jul 8, 2019 · Terminated
- Sevoflurane, USP (Inhalation Anesthetic), Rx Only, 250 mL Amber Bottle. Manufactured By: Piramal Critical Care, 3950…D-1262-2014 · Class II · Apr 7, 2014 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports